Literature DB >> 4029253

Plasma protein binding of ritodrine at parturition and in nonpregnant women.

A S Gross, K F Brown.   

Abstract

The binding of ritodrine HCl in whole plasma from healthy nonpregnant women, parturients and matched umbilical venous plasma and in solutions of HSA and alpha 1-AGP has been studied by equilibrium dialysis. Binding to plasma from nonpregnant subjects and HSA was independent of ritodrine concentration over a wide range. The free fraction in plasma was high and significantly different between groups of nonpregnant (alpha = 0.64), parturient (alpha = 0.68) and matched umbilical venous plasma (alpha = 0.75). It would seem that variability in transplacental transfer of ritodrine, as a result of plasma binding fluctuations, will be minor.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4029253     DOI: 10.1007/bf00544372

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  5 in total

1.  Factors affecting drug-protein binding in the plasma of newborn infants.

Authors:  S Wallace
Journal:  Br J Clin Pharmacol       Date:  1976-06       Impact factor: 4.335

2.  Human albumin from cord blood: some distinctive characteristics.

Authors:  M L Gallango; N Montiel; R Suinaga
Journal:  Biochem Med       Date:  1981-10

3.  Ritodrine concentrations in maternal and fetal serum and amniotic fluid.

Authors:  M van Lierde; K Thomas
Journal:  J Perinat Med       Date:  1982       Impact factor: 1.901

4.  Serum level of ritodrine in man.

Authors:  R Gandar; L W de Zoeten; J B van der Schoot
Journal:  Eur J Clin Pharmacol       Date:  1980-02       Impact factor: 2.953

5.  Ritodrine hydrochloride: a betamimetic agent for use in preterm labor. I. pharmacology, clinical history, administration, side effects, and safety.

Authors:  T P Barden; J B Peter; I R Merkatz
Journal:  Obstet Gynecol       Date:  1980-07       Impact factor: 7.661

  5 in total
  1 in total

Review 1.  Clinical pharmacokinetics of beta-agonists.

Authors:  D J Morgan
Journal:  Clin Pharmacokinet       Date:  1990-04       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.